On the role of interleukin-10 in the induction and maintenance of specific transplantation tolerance. 1994

V Holán, and M Kosarová, and M Lipoldová
Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Praha, Czech Republic.

The role of a cytokine synthesis inhibitory factor, interleukin-10 (IL-10), in the induction and maintenance of neonatal transplantation tolerance was studied in mice. We showed that neonatal spleen cells (NSC) significantly inhibited interleukin-2 (IL-2) production by activated T cells from adult mice. Simultaneously we demonstrated a high expression of the IL-10 gene in stimulated spleen cells from newborn mice. However, neutralizing monoclonal antibody (mAb) anti-IL-10 did not abolish the NSC-mediated suppression of IL-2 production. IL-10, therefore, does not appear to be the principal inhibitory molecule responsible for the suppression of IL-2 production. Similarly, specific alloantigen-activated spleen cells from adult tolerant animals were profoundly hyporeactive in IL-2 production. This hyporeactivity was not reversed to a positive reactivity in the presence of mAb anti-IL-10. In addition, anti-IL-10 antibody enhanced proliferation in mixed lymphocyte cultures of cells from both control and tolerant animals, but the antibody did not abrogate specific hyporeactivity of cells from tolerant mice. These results thus showed that newborn animals were nonspecifically and tolerant animals specifically deficient in IL-2 production, but that IL-10 in neither case appeared to be responsible for this IL-2 hyporeactivity.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals

Related Publications

V Holán, and M Kosarová, and M Lipoldová
April 1994, The Journal of experimental medicine,
V Holán, and M Kosarová, and M Lipoldová
June 1995, Transplantation,
V Holán, and M Kosarová, and M Lipoldová
June 1987, The Journal of experimental medicine,
V Holán, and M Kosarová, and M Lipoldová
September 1998, Leukemia & lymphoma,
V Holán, and M Kosarová, and M Lipoldová
January 1984, Allergie und Immunologie,
V Holán, and M Kosarová, and M Lipoldová
April 1989, Journal of leukocyte biology,
V Holán, and M Kosarová, and M Lipoldová
December 2002, European journal of immunology,
V Holán, and M Kosarová, and M Lipoldová
May 2002, Transplant immunology,
V Holán, and M Kosarová, and M Lipoldová
February 2007, Transplant immunology,
Copied contents to your clipboard!